{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:13:35Z","timestamp":1788416015717,"version":"build-2803163510"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To analyze the correlation between the expression of lysine deacetylase 5 (SIRT5), histone H2A and topoisomerase II\u03b1 (TOP2A) protein with clinical stage and survival in cervical cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The expression levels of SIRT5, H2A and TOP2A proteins were detected by immunohistochemical two-step method in paraffin-embedded tissue blocks from 65 patients with cervical cancer (21 cases of stage IB, 9 cases of stage IIA and 35 cases of stage IIIC1p). The expression distribution and positive rate of SIRT5, H2A and TOP2A proteins in tumor tissues of patients with different stages of cervical cancer were compared, and furthermore, survival analysis was conducted using Kaplan\u2013Meier estimations and Cox regression modeling to pinpoint independent prognostic factors, along with the correlations among the expression levels of these three proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression of SIRT5 and TOP2A increased significantly with the advancing clinical stage, whereas H2A expression showed a significant decrease with higher stage, and the difference was statistically significant (P &amp;lt; 0.05). As of April 2026, the median follow-up duration was 29 months (12\u201351 months). The 3-year overall survival (OS) and progression-free survival (PFS) of the SIRT5 negative group were significantly higher than those of the positive group (92% vs 49%, 90% vs 18%), and the differences were statistically significant (P &amp;lt; 0.05). In the H2A group, the 3-year OS and PFS of the positive group were significantly higher than those of the negative group (93% vs 64%, 86% vs 50%), and the differences were statistically significant (P &amp;lt; 0.05). The 3-year OS and FPS in the TOP2 A negative group were significantly higher than those in the positive group (87% vs 47%, 83% vs 19%), and the differences were statistically significant (P &amp;lt; 0.05). Multivariate Cox analysis identified SIRT5 positive expression (HR = 2.64, 95% CI: 1.08\u20135.60, P = 0.047) (HR = 2.24, 95% CI: 1.04\u20135.35, P = 0.004), TOP2A positive expression (HR = 2.96, 95% CI: 1.60\u20134.50, P = 0.018) (HR = 1.97, 95% CI: 1.29\u20134.13, P = 0.025) and H2A negative expression(HR = 0.29, 95% CI: 0.02\u20130.93, P = 0.032) (HR = 0.71, 95% CI: 0.08\u20130.98, P = 0.027) expression as independent predictors of OS and PFS. Spearman correlation analysis showed that the expression of SIRT5 protein was negatively correlated with the expression of H2A protein (r = -0.678, P = 0.000), and positively correlated with the expression of TOP2A (r = 0.652, P = 0.000).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>With the increase of clinical stage of cervical cancer, the positive expression rates of SIRT5 and TOP2A were significantly increased, and their high expression was related to the poor prognosis of patients. On the contrary, the negative expression rate of H2A increased with the advancing stage, and the prognosis of negative expression was worse. The above indicators had potential biomarker value for predicting the efficacy of cervical cancer treatment and the survival of patients. SIRT5 expression was negatively correlated with H2A and positively correlated with TOP2A. The potential regulatory mechanism among these three proteins warrant further in-depth investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1899320","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:23:02Z","timestamp":1788412982000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The expression and clinical significance of SIRT5, H2A and TOP2A in cervical cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Fenghu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]},{"name":"Department of Oncology, School of Clinical Medicine, Guizhou Medical University","place":["Guiyang, China"]},{"name":"Department of Gynecological Oncology, The Affiliated Cancer Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]},{"name":"Department of Gynecological Oncology, The Affiliated Cancer Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Gynecological Oncology, The Affiliated Cancer Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]},{"name":"Department of Gynecological Oncology, The Affiliated Cancer Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]},{"name":"Department of Gynecological Oncology, The Affiliated Cancer Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]},{"name":"Department of Gynecological Oncology, The Affiliated Cancer Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengfa","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]},{"name":"Department of Oncology, School of Clinical Medicine, Guizhou Medical University","place":["Guiyang, China"]},{"name":"Department of Gynecological Oncology, The Affiliated Cancer Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]},{"name":"Department of Oncology, School of Clinical Medicine, Guizhou Medical University","place":["Guiyang, China"]},{"name":"Department of Gynecological Oncology, The Affiliated Cancer Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.0693","article-title":"National breast, cervical, and colorectal cancer screening use in federally qualified health centers","volume":"184","author":"Amboree","year":"2024","journal-title":"JAMA Intern Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2024.101157","article-title":"Women's ignorance and misperception of cervical cancer: Evidence-based analysis from low- and middle-income countries","volume":"54","author":"Sudha","year":"2025","journal-title":"Curr Probl Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1002-3674.2022.05.002","article-title":"1990-2019 Analysis of the changing trends and predictions of the disease burden of cervical and breast cancer among Chinese women","volume":"39","author":"Cui","year":"2022","journal-title":"Chinese health statistics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2025.0057","article-title":"Cervical cancer, version 2.2026, NCCN clinical practice guidelines in oncology","volume":"23","author":"Abu-Rustum","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/jso.27911","article-title":"Quality of life post cervical cancer treatment: A comparison between radical surgery approach and radiotherapy and chemotherapy","volume":"130","author":"Tokarski","year":"2024","journal-title":"J Surg Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1531246","article-title":"Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development","volume":"16","author":"Ke","year":"2025","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.freeradbiomed.2022.02.014","article-title":"Overexpression of SLC25A51 promotes hepatocellular carcinoma progression by driving aerobic glycolysis through activation of SIRT5","volume":"182","author":"Bai","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153943","article-title":"SIRT5 is involved in the proliferation and metastasis of breast cancer by promoting aerobic glycolysis","volume":"235","author":"He","year":"2022","journal-title":"Pathol Res Pract"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/biom14080993","article-title":"The function of H2A histone variants and their roles in diseases","volume":"14","author":"Yin","year":"2024","journal-title":"Biomolecules"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add4920","article-title":"Untangling the roles of TOP2A and TOP2B in transcription and cancer","volume":"8","author":"Uusk\u00fcla-Reimand","year":"2022","journal-title":"Sci Adv"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S240577","article-title":"TOP2A promotes cell migration, invasion and epithelial-mesenchymal transition in cervical cancer via activating the PI3K\/AKT signaling","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.7150\/thno.97320","article-title":"Mitochondrial sirtuins in cancer: A revisited review from molecular mechanisms to therapeutic strategies","volume":"14","author":"Shen","year":"2024","journal-title":"Theranostics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11418-024-01871-6","article-title":"SIRT5: a potential target for discovering bioactive natural products","volume":"79","author":"Xie","year":"2025","journal-title":"J Nat Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2023.02.008","article-title":"Role of SIRT5 in cancer. Friend or foe","volume":"209","author":"Lagunas-Rangel","year":"2023","journal-title":"Biochimie"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201745124","article-title":"SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer","volume":"19","author":"Chen","year":"2018","journal-title":"EMBO Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/srep17940","article-title":"SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer","volume":"5","author":"Lv","year":"2015","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11788","article-title":"\u03b3-H2AX as a potential indicator of radiosensitivity in colorectal cancer cells","volume":"20","author":"Kawashima","year":"2020","journal-title":"Oncol Lett"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.701736","article-title":"H2AFZ is a prognostic biomarker correlated to TP53 mutation and immune infiltration in hepatocellular carcinoma","volume":"11","author":"Dong","year":"2021","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019101863","article-title":"Histone H2A phosphorylation recruits topoisomerase II\u03b1 to centromeres to safeguard genomic stability","volume":"39","author":"Zhang","year":"2020","journal-title":"EMBO J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12920-020-00800-2","article-title":"TOP2A and CENPF are synergistic master regulators activated in cervical cancer","volume":"13","author":"Yu","year":"2020","journal-title":"BMC Med Genomics"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1899320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:23:03Z","timestamp":1788412983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1899320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":20,"alternative-id":["10.3389\/fonc.2026.1899320"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1899320","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1899320"}}